and were suggested to be responsible for the kinase activity of TFIIH. Furthermore, a Saccharomyces cerevisiae M015-related kinase, KIN28, was identified as a p33 kinase subunit of yeast TFIIH (16). The TFIIH-associated KIN28 is included in the holo-TFIIH associated with transcription but can be separated from a form of TFIIH still functional in DNA repair (17).
activity, indicating that M015 is critical for polymerase phosphorylation. Nonetheless, these mutant TFIIH preparations were fully functional (in vitro) in both basal and activated transcription. These results indicate that CTD phosphorylation is not required for transcription with a highly purified system. RNA polymerase II (Pol II) transcription requires the assembly of general transcription factors and Pol II on promoter DNA. One of the general transcription factors TFIIH, has been found to contain DNA-dependent helicase, ATPase, and kinase activities, which may be critical for initiation of transcription (1) (2) (3) . TFIIH has also been implicated in DNA nucleotide excision repair (4) (5) (6) , and mutations in at least two subunits of the multiprotein TFIIH complex are responsible for forms of Xeroderma pigmentosum, Cockayne's syndrome, and trichothiodystrophy (reviewed in ref. 7) .
Recently, M015 and cyclin H, originally identified as subunits of the cyclin-dependent kinase (CDK)-activating kinase CAK (8) (9) (10) (11) (12) , were identified in purified TFIIH fractions (13) (14) (15) and were suggested to be responsible for the kinase activity of TFIIH. Furthermore, a Saccharomyces cerevisiae M015-related kinase, KIN28 , was identified as a p33 kinase subunit of yeast TFIIH (16) . The TFIIH-associated KIN28 is included in the holo-TFIIH associated with transcription but can be separated from a form of TFIIH still functional in DNA repair (17) .
The C-terminal domain (CTD) of Pol II is a substrate for the TFIIH kinase (18) , and one of the functions of TFIIH may be to regulate polymerase activity by modulating CTD phosphorylation. The exact role of CTD phosphorylation in transcription remains elusive. The CTD of polymerase entering the preinitiation complex (19) or stalled close to the promoter (20) is not phosphorylated, whereas the elongating polymerase is highly phosphorylated (21) . In addition, CTD that is not phosphorylated interacts with the TATA-binding protein (TBP) component of TFIID (22) and with TFIIE (23) , leading to the notion that phosphorylation of CTD would be critical for promoter clearance. On the other hand, kinase inhibitor studies have suggested that CTD phosphorylation is not required for basal transcription (24) . Another model suggested by studies with yeast polymerase holoenzymes suggests that
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CTD phosphorylation might be involved in activated transcription (25, 26) . Here the role of M015 and cyclin H in CTD phosphorylation and the effects of this phosphorylation on transcription are discussed.
MATERIALS AND METHODS
Antibodies. A monoclonal antibody (mAb) against p62 (mAb 3c9) was provided by J.-M. Egly (Centre National de la Recherche Scientifique, Illkirch, France); the M015 polyclonal rabbit serum was raised against a 15-amino-acid Cterminal peptide; the cyclin H polyclonal rabbit serum was raised against a glutathione S-transferase (GST)-cyclin H fusion protein; the p89 antiserum was a polyclonal rabbit serum against a GST-p89-N-terminal fragment; and commercial preparations of the polyclonal rabbit CDK2 antibody (M2; Santa Cruz, Biotechnology, Santa Cruz, CA) and Myc mAb 9E10 (Cambridge Research Biochemicals) were used.
Transfections. Fifteen micrograms of plasmids encoding wild-type or mutant MO15 cDNAs with C-terminal triple Myc-epitope tags (46) in pcDNA3 (Invitrogen) or 15 ,ug of pcDNA3 together with 15 ,g of an untagged cyclin H cDNA in pcDNA3 were transfected into human bone sarcoma U-2 OS cells by calcium phosphate coprecipitation. This particular cell line was used because of its high transfectability. Fortyeight hours after transfection, cells were washed in phosphatebuffered saline and lysed in ELB (150 mM NaCl/50 mM Hepes, pH 7.5/5 mM EDTA/0.1% Nonidet P-40 containing 10 Ag each of aprotinin and leupeptice per ml, 0.2 mM phenylmethylsulfonyl fluoride, 10 mM f3-glycerophosphate, and 5 mM NaF) for immunoprecipitation.
Immunoblotting and Immunoprecipitations. Highly purified HeLa cell TFIIH (10 ,ul) Transcription Assays. Basal transcription reactions were done by published procedures using highly purified factors described above for kinase assays with the addition of nucleotides as described (28) (29) and recombinant yeast GAL4-herpes simplex virus VP16 fusion protein as a transactivator were included as described (47) . The adenovirus major late promoter (MLP) used for activated transcription contained three GAL4 binding sites (390-nt RNA; marked "activated" in Fig. 4D ); the same promoter without these sites (210-nt RNA; marked "basal" in Fig. 4D ) was used as an internal controf for basal transcription.
RESULTS
Western blotting analysis of TFIIH purified from human HeLa cells indicated that the MO15 kinase and cyclin H were present in the TFIIH preparation at amounts comparable to the p62 subunit of TFIIH (30) (Fig. 1A ). This confirms reports of copurification of M015 (13) and cyclin H (15) The apparent dual role of CAK as a CDK-activating kinase and a CTD kinase in the TFIIH was compared (Fig. 2) .
Confirming previous reports (18, 33) , the CTD kinase activity of TFIIH was enhanced when Pol II was recruited to the preinitiation complex by the presence of other basal factors and DNA (Fig. 2A) . ylated Pol II. form. However, the ability of the TFIIH complex to phosphorylate CDK2 was not enhanced or suppressed under these conditions. The stimulation of CID kinase activity by DNA and other basal factors was also observed when, instead of using the TFIIH preparation, an anti-MO15 immunoprecipitate from whole-cell lysates was used ( Fig. 2A) , supporting the earlier results indicating that anti-MO15 or anti-cyclin H immunoprecipitates include virtually all of the components of TFIIH (see Fig. 1 ).
The difference in the relative activities of the TFIIH preparation or of the anti-MO15 immunoprecipitates toward the Pol II and CDK2 substrates (Fig. 2, compare lanes 1 with lanes   7 ) suggested the existence of at least two pools of MO15. To investigate this notion further, MO15-associated kinase activities were analyzed from fractions of HeLa cell nuclear extracts eluted at increasing salt concentrations from a phosphocellulose column (Fig. 2B, lanes 3-6) . A substantial amount of GST-CDK2 kinase activity was observed in both fractions B and C, while Pol II kinase activity was found almost exclusively in fraction C. Thus, cellular MO15 is present in at least two pools, of which the B fraction pool preferentially phosphorylates CDK2 as opposed to Pol II and thus would be expected not to contain substantial TFIIH activity.
Since immunoprecipitates with MO15-associated proteins could substitute for the purified TFIIH in a DNA-dependent kinase assay, similar preparations were tested for their ability to substitute for TFIIH in a TFIIH-dependent basal transcription assay (Fig. 3) . Anti-MO15 immunoprecipitates from the phosphocellulose column fraction C provided substantial TFIIH activity for the in vitro basal transcription assay (Fig.   3A) , as evidenced by the accumulation of a 210-nt transcript Fig. 2B ) and supported the conclusion that the B fraction pool of M015 is not associated with TFIIH, whereas the majority of the C fraction po'ol is TFIIH-associated.
Immunoprecipitation with anti-MO15 as a source of TFIIH was extended to whole-cell lysates from U-2 OS cells (Fig. 3B,  lane 6 ). Moreover, transcriptionally active preparations of TFIIH were recovered in anti-Myc immunoprecipitates from U-2 OS cells transiently transfected with a plasmid expressing Myc-tagged MO15 protein (Fig. 3B, lane 4) . The ability to use plasmid-encoded M015 proteins allowed the testing of mutants of M015 to analyze directly the role of M015 in TFIIH functions. Interestingly, a kinase-deficient Asp-155 -> Asn mutant (see below) of M015, demonstrated full basal transcription activity in this assay (Fig. 3B, lane 5) .
Myc-tagged Lys-41 --Met (12) and Asp-155 --Asn mutants of M015 generated kinase-deficient forms of M015 based on analogous mutations studied in other CDKs (34, 35) . In transient transfections of cyclin H and M015 into U-2 OS cells, association of both M015 mutants with cyclin H and with the p62 subunit of TFIIH was indistinguishable from their association with the wild-type protein (Fig. 4A) , indicating appropriate complex formation. However, anti-Myc preparations from cells transfected with either mutant were unable to phosphorylate either GST-CDK2 or Pol II in vitro (Fig. 4B,  lanes 1-4) . Anti-Myc preparations from the Asp-155 -> Asn mutant M015 transfections were also unable to phosphorylate Pol II under transcription conditions in the presence of basal factors and template (Fig. 4B, lanes 9-11) , indicating that MQ15 is absolutely required for the CID kinase activity of TFIIH. Kinase reactions with anti-cyclin H preparations containing cyclin H and associated proteins from both transfected and untransfected cells showed only a slightly decreased kinase activity after transfections with mutants (Fig. 4B, lanes 5-8) due to high levels of endogenous M015 (data not shown).
Although these results do not formally rule out the possibility that TFIIH would contain yet another kinase completely dependent on M015 activity, the stoichiometry of M015 in TFIIH and the lack of their kinases among the detectable TFIIH polypeptides strongly argue against this possibility. These results also suggest that there is only one subunit of M015 per TFIIH complex, sintce endogenous M015, which was more abundant in the transfected cells, was not recovered in the anti-Myc immunoprecipitations as determined by the lack of kinase activity.
To ensure that the transcription activity associated with TFIIH containing Asp-155 --Asn MO15 mutant (Fig. 3B) was not specific for this particular mutation or caused by supersaturating levels of TFIIH, immunoprecipitates from both mutants .were used for titrations (Fig. 4C) . The kinasedeficient TFIIH preparations were indistinguishable from wild-type TFIIH in supporting TFIIH-dependent basal transcription. In all these reactions, the titrations indicate that TFIIH was the limiting activity (as in Fig. 3B ) and thus support the concept that C kD kinase activity is dispensable' for basal transcription.
One proposed role for CTD phosphorylation is to render the polymerase responsive to upstream activators. Kinase-deficient preparations of TFIIH were assayed in a defined activation system with purified holo-TFIIH, recombinant GAL4-VP16 as a transactivator, and recombinant HMG-2 and PC4 as coactivators. Under these conditions, kinase activity was found to be dispensable for activation (Fig. 4D ). (24) . In addition, the presence of a C-terminal domain on Pol II was only required for a subset of promoters in vitro (40) , and TFIIH (and the CTD kinase therein) has been found to be dispensable for the activity of some promoters (28) .
The dispensability of the CTD for transcription in vitro may reflect the absence of negative regulatory factors present in more physiologic circumstances (41) . The presence of the CTD for Pol II is vital for yeast cell growth (42) , and mutations that alter the effects of CTD deletions alter proteins found in a complex associated with CTD in yeast (43) . Two recent studies suggest that the CTD kinase of TFIIH may be mediating some of these transcriptional effects. A temperature-sensitive yeast TFIIH kinase, with mutations in KIN28, is deficient for transcription in vivo at a restrictive temperature (Mary J. Cismowski, Geoffrey M. Laff, Mark J. Solomton, and Steven I. Reed, personal communication). In addition, Roy et at (13) found that M015 antibodies inhibited transcription and DNA repair when microinjected into cells. However, this inhibition is difficult to interpret, as it could reflect either sequestration of MO15 kinase activity or disruption of the TFIIH complex by the antibodies (13 
